| Name | Title | Contact Details |
|---|
ABB OPTICAL GROUP is dedicated to being the premier optical industry platform - our mission is to deliver tailored business solutions and world class customer service, to help each eye care practitioner to exceed their patient`s expectations. Our dynamic vision care organization supplies 30,000 eye care professionals, retail stores, hospitals and universities, with brand name contact lenses and finished ophthalmic lenses and manufactures fully customizable gas permeable and custom specialty soft lenses. In addition, our Digital Eye Lab provides eye care professionals with digitally surfaced freeform ophthalmic lens designs and AR coatings. ABB also offers practice building tools such as pricing strategy tools, business reviews, annual supply staff training and ecommerce solutions, including patient ordering websites yourlens.com and primaryecp.com. ABB OPTICAL GROUP is a New Mountain Capital portfolio company, formed through the merger of ABB CONCISE Optical Group and Optical Distributor Group.
InfraScan, Inc. is a medical device company that focuses on developing, commercializing, and distributing hand-held diagnostic devices for head injury and stroke assessment based on near infrared (NIR) technology. The Infrascanner enables clinicians to detect effectively, conveniently, and accurately intracranial bleeding in patients with head trauma. Intracranial hematomas are an important treatable cause of secondary brain injury in patients with head trauma. Recent statistics from Iraq shows that 30% of all wounded in action have head injuries; of them 40% have brain hematomas. Dr. Britton Chance (University of Pennsylvania) and Dr. Claudia Robertson (Baylor College of Medicine) invented a NIR system for detection of brain Hematomas and tested it successfully in 305 patients in Baylor. An entrepreneurial team formed a company around this technology in Collaboration with Drexel University and won the Wharton Business Plan competition in April 2004 and the second prize at the global business plan competition in Singapore in October 2004. Office of Naval Research funded the company in May 2004. The company also attracted $1.5M in funding from BioAdvance, the Biotechnology Greenhouse of Southeastern Pennsylvania, from Ben Franklin Technology Partners of Southeastern Pennsylvania, and from Philadelphia Industrial Development Corporation. A multicenter clinical study to support an FDA submission started in July 2006, and on February 2008 an application was submitted to the FDA. After 4 years of review, the FDA cleared Infrascanner Model 1000 as a DeNovo medical technology in December 2011. In January 2013 the FDA cleared the 510(k) of Infrascanner Model 2000.
Owens Healthcare is a Redding, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Charm Health is a Bardon Qld, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Accelmed is an investment firm focused on value creation for medical device companies and technologies. Accelmed was founded in 2009 by Mori Arkin and Uri Geiger and invests in small and mid-cap private and public companies.